Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Taylor L. Gist"'
Autor:
Martyn A. Sharpe, Andrew D. Livingston, Taylor L. Gist, Pardip Ghosh, Junyan Han, David S. Baskin
Publikováno v:
EBioMedicine, Vol 2, Iss 9, Pp 1122-1132 (2015)
The last major advance in the treatment of glioblastoma multiforme (GBM) was the introduction of temozolomide in 1999. Treatment with temozolomide following surgical debulking extends survival rate compared to radiotherapy and debulking alone. Howeve
Externí odkaz:
https://doaj.org/article/9a0a9c3e875642ee9b1dd58b1d72a711
Publikováno v:
Journal of Toxicology, Vol 2013 (2013)
The role of thimerosal containing vaccines in the development of autism spectrum disorder (ASD) has been an area of intense debate, as has the presence of mercury dental amalgams and fish ingestion by pregnant mothers. We studied the effects of thime
Externí odkaz:
https://doaj.org/article/ca74f657a0a946b7948ebd08fedb5948
Publikováno v:
Journal of Toxicology, Vol 2013 (2013)
It has been postulated that androgen overexposure in a susceptible person leads to excessive brain masculinization and the autism spectrum disorder (ASD) phenotype. In this study, the responses to estradiol (E2), dihydrotestosterone (DHT), and dichlo
Externí odkaz:
https://doaj.org/article/deb3ee3330db4ec2b9ad212d1e3cb704
Publikováno v:
Journal of NeuroInterventional Surgery. 6:614-617
Background Endovascular treatment of intracranial aneurysms via flow diversion has become increasingly popular over the past several years. The flow redirection endoluminal device (FRED; Microvention, Tustin, California, USA) system is a next generat
Autor:
Orlando M. Diaz, Taylor L. Gist, Gustavo C. Roman, Chandan Krishna, David A. Cech, Leonardo Rangel-Castilla
Publikováno v:
Journal of NeuroInterventional Surgery. 6:e16-e16
A 64-year-old man with a history of traumatic brain injury 4 years previously presented with progressive cognitive decline and gait abnormality. MRI revealed diffusion restriction in the bilateral centrum semiovale and multiple serpiginous flow voids
Autor:
Pardip Ghosh, David S. Baskin, Andrew D. Livingston, Martyn A. Sharpe, Taylor L. Gist, Junyan Han
Publikováno v:
EBioMedicine, Vol 2, Iss 9, Pp 1122-1132 (2015)
The last major advance in the treatment of glioblastoma multiforme (GBM) was the introduction of temozolomide in 1999. Treatment with temozolomide following surgical debulking extends survival rate compared to radiotherapy and debulking alone. Howeve